Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equitable C Pref | EQH-C | Jan 10, 2025 | 17.38 | -2.47 |
Equitable Holdings | EQH | Jan 10, 2025 | 48.08 | -1.90 |
Equity Bancshares A | EQBK | Jan 10, 2025 | 39.81 | -3.82 |
Equity Commonwealth | EQC | Jan 10, 2025 | 1.68 | -6.67 |
Equity Commonwealth D Pref | EQC-D | Jan 10, 2025 | 25.05 | 0.00 |
Equity Income Wisdomtree | DHS | Jan 10, 2025 | 91.55 | -1.44 |
Equity Lifestyle Properties | ELS | Jan 10, 2025 | 64.47 | -1.95 |
Equity Residential | EQR | Jan 10, 2025 | 66.98 | -0.80 |
Equus Total Return | EQS | Jan 10, 2025 | 1.13 | +10.78 |
EQV Ventures Acquisition | EQV | Jan 10, 2025 | 9.99 | -0.20 |
Erasca | ERAS | Jan 10, 2025 | 2.37 | -14.00 |
Erayak Power Solution Group A | RAYA | Jan 10, 2025 | 1.33 | +3.91 |
Ericsson B ADR | ERIC | Jan 10, 2025 | 8.13 | -2.17 |
Erie Indemnity A | ERIE | Jan 10, 2025 | 389.24 | -3.02 |
Ermenegildo Zegna N.V. | ZGN | Jan 10, 2025 | 7.74 | -2.40 |
Ero Copper | ERO | Jan 10, 2025 | 14.41 | +0.49 |
ESAB | ESAB | Jan 10, 2025 | 115.04 | -2.19 |
Escalade | ESCA | Jan 10, 2025 | 14.29 | -2.32 |
Esco Technologies | ESE | Jan 10, 2025 | 128.92 | -2.47 |
ESGL | ESGL | Jan 10, 2025 | 1.41 | +11.90 |
ESH Acquisition | ESHA | Jan 10, 2025 | 11.24 | 0.00 |
Eshallgo | EHGO | Jan 10, 2025 | 3.27 | -6.57 |
Esperion Therapeutics | ESPR | Jan 10, 2025 | 2.34 | +7.83 |
Espey Mfg & Electronics | ESP | Jan 10, 2025 | 27.51 | -0.61 |
Esquire Financial | ESQ | Jan 10, 2025 | 78.20 | -3.46 |
ESS Tech | GWH | Jan 10, 2025 | 5.52 | -1.60 |
ESSA Bancorp | ESSA | Jan 10, 2025 | 18.97 | +1.83 |
ESSA Pharma | EPIX | Jan 10, 2025 | 1.74 | -4.40 |
Essent Group | ESNT | Jan 10, 2025 | 54.48 | -1.02 |
Essential Properties Realty Trust | EPRT | Jan 10, 2025 | 30.58 | -3.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.